Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

VTGN

Vistagen Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · VTGN

All alert types
0.17 USD 0.00 -1.41%
As of Oct 30, 2026 Extended hours 0.17 +0.71%
Bid
0.17 × 1
Ask
0.17 × 2
0.1655 Day range 0.172
0.1683 52-week range 4.90
YTD
-74.50%
1 year
-95.51%
Open
0.1707
Prev close
0.1707
Mkt cap
7.47M
Vol
594.79K
Avg vol
12.32M
EPS
-1.66
P/E
0.00
Div yield
0.00%
More statistics
Low
0.1655
High
0.172
Forward P/E
-1.49
Beta
0.00
Short ratio
1.69
Inst. own
53.63%
Dividend
0.00
Ex-div date
Earnings
Feb 11, 2025
50-d avg
2.81
200-d avg
3.60
1y target
13.00

5D chart

Chart tools
Interval
1m5m15m30m
VTGN five-day price chart0.170.170.170.180.18Oct 26Oct 27Oct 28Oct 30

Financial health

Altman Z-Score

-24.25 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 5

Valuation

P/E -0.3×
FY 2017: -1.4×FY 2018: -0.9×FY 2019: -1.5×FY 2020: -0.9×FY 2021: -4.3×FY 2022: -5.0×FY 2023: -0.4×FY 2024: -3.6×FY 2025: -1.5×FY 2026: -0.3×
FY 2017 5y median -1.5× FY 2026
P/S 17.1×
FY 2017: 11.8×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 168×FY 2022: 221×FY 2023: -110×FY 2024: 98.2×FY 2025: 159×FY 2026: 17.1×
FY 2017 5y median 98.2× FY 2026
P/B 0.6×
FY 2017: 24.0×FY 2018: 1.9×FY 2019: 5.4×FY 2020: -3.4×FY 2021: 2.0×FY 2022: 3.8×FY 2023: 2.1×FY 2024: 0.9×FY 2025: 1.1×FY 2026: 0.6×
FY 2017 5y median 1.1× FY 2026
P/FCF -0.3×
FY 2017: -2.0×FY 2018: -1.4×FY 2019: -2.6×FY 2020: -1.2×FY 2021: -14.9×FY 2022: -5.4×FY 2023: -0.5×FY 2024: -4.0×FY 2025: -1.8×FY 2026: -0.3×
FY 2017 5y median -1.8× FY 2026
EV/EBITDA 0.1×
FY 2017: -1.2×FY 2018: -0.2×FY 2019: -1.0×FY 2020: -1.1×FY 2021: -4.8×FY 2022: -3.8×FY 2023: -0.2×FY 2024: 0.4×FY 2025: -0.2×FY 2026: 0.1×
FY 2017 5y median -0.2× FY 2026
EV/Sales -6.3×
FY 2017: 9.5×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 77.2×FY 2022: 163×FY 2023: -49.0×FY 2024: -11.8×FY 2025: 23.8×FY 2026: -6.3×
FY 2017 5y median -6.3× FY 2026
FCF Yield -305.3%
FY 2017: -50.8%FY 2018: -70.1%FY 2019: -38.7%FY 2020: -81.6%FY 2021: -6.7%FY 2022: -18.5%FY 2023: -199.3%FY 2024: -24.8%FY 2025: -54.8%FY 2026: -305.3%
FY 2017 5y median -54.8% FY 2026

Profitability

Gross Margin 100.0%
FY 2017: 100.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%FY 2026: 100.0%
FY 2017 5y median 100.0% FY 2026
Operating Margin -5683.7%
FY 2017: -819.9%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -1646.1%FY 2022: -4308.7%FY 2023: 26109.3%FY 2024: -3103.5%FY 2025: -11517.1%FY 2026: -5683.7%
FY 2017 5y median -4308.7% FY 2026
Net Margin -5491.3%
FY 2017: -820.4%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -1646.1%FY 2022: -4307.2%FY 2023: 26100.4%FY 2024: -2759.6%FY 2025: -10579.8%FY 2026: -5491.3%
FY 2017 5y median -4307.2% FY 2026
ROE -196.2%
FY 2017: -1665.4%FY 2018: -207.4%FY 2019: -347.5%FY 2020: 362.6%FY 2021: -19.5%FY 2022: -73.8%FY 2023: -490.5%FY 2024: -25.7%FY 2025: -73.0%FY 2026: -196.2%
FY 2017 5y median -73.8% FY 2026
ROIC -197.3%
FY 2017: -426.7%FY 2018: -143.8%FY 2019: -217.9%FY 2020: -592.0%FY 2021: -17.2%FY 2022: -68.9%FY 2023: -346.5%FY 2024: -27.7%FY 2025: -77.4%FY 2026: -197.3%
FY 2017 5y median -77.4% FY 2026
ROA -143.5%
FY 2017: -276.3%FY 2018: -127.2%FY 2019: -175.5%FY 2020: -359.9%FY 2021: -16.6%FY 2022: -64.0%FY 2023: -280.9%FY 2024: -23.7%FY 2025: -61.0%FY 2026: -143.5%
FY 2017 5y median -64.0% FY 2026

Growth (YoY)

Revenue 161.1%
FY 2017: 0.0%FY 2018: -100.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 1.8%FY 2023: -120.5%FY 2024: 568.7%FY 2025: -54.3%FY 2026: 161.1%
FY 2017 FY 2026
Operating Income -28.9%
FY 2017: 42.6%FY 2018: -38.6%FY 2019: -72.9%FY 2020: 18.7%FY 2021: 10.2%FY 2022: -166.4%FY 2023: -24.0%FY 2024: 44.3%FY 2025: -69.5%FY 2026: -28.9%
FY 2017 FY 2026
EPS (diluted) -9.6%
FY 2017: 94.9%FY 2018: 24.2%FY 2019: 16.6%FY 2020: 45.0%FY 2021: -3.7%FY 2022: 49.9%FY 2023: -15.3%FY 2024: 82.1%FY 2025: -9.9%FY 2026: -9.6%
FY 2017 FY 2026
Free Cash Flow -57.1%
FY 2017: -55.2%FY 2018: -20.8%FY 2019: -62.3%FY 2020: -7.2%FY 2021: 21.6%FY 2022: -268.1%FY 2023: -9.8%FY 2024: 48.2%FY 2025: -63.4%FY 2026: -57.1%
FY 2017 FY 2026

Financial Health

Current Ratio 3.7×
FY 2017: 2.5×FY 2018: 7.6×FY 2019: 4.9×FY 2020: 0.6×FY 2021: 24.9×FY 2022: 12.3×FY 2023: 3.8×FY 2024: 23.6×FY 2025: 6.5×FY 2026: 3.7×
FY 2017 5y median 6.5× FY 2026
Quick Ratio 3.7×
FY 2017: 2.5×FY 2018: 7.6×FY 2019: 4.8×FY 2020: 0.6×FY 2021: 24.9×FY 2022: 12.3×FY 2023: 3.8×FY 2024: 23.6×FY 2025: 6.5×FY 2026: 3.7×
FY 2017 5y median 6.5× FY 2026
Debt / Equity 0.0×
FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -0.7×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.2×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 0.4×
FY 2017: 0.3×FY 2018: 0.7×FY 2019: 0.5×FY 2020: -0.1×FY 2021: 5.7×FY 2022: 1.4×FY 2023: 0.2×FY 2024: 4.1×FY 2025: 1.3×FY 2026: 0.4×
FY 2017 5y median 1.3× FY 2026
Interest Coverage 0.0×
FY 2017: -2050×FY 2018: -1595×FY 2019: -3070×FY 2020: -1332×FY 2021: -1380×FY 2022: 0.0×FY 2023: -2577×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 8515.1%FY 2018: 7976.6%FY 2019: 3000.7%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 385.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: -12256.8%FY 2018: -7182.5%FY 2019: -4635.7%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -1978.8%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-03-31